Literature DB >> 1760412

Perforin and granzyme B as markers for acute rejection in heart transplantation.

M V Clément1, P Haddad, A Soulié, C Benvenuti, M G Lichtenheld, E R Podack, N Sigaux, M Sasportes.   

Abstract

Histological analysis of endomyocardial biopsies (EMB) is regarded as the most satisfactory technique for monitoring crisis of rejection in heart transplanted patients. In this study, 42 biopsies from 14 patients who underwent heart transplantation were examined. Three patients did not present any rejection crisis at the date of the biopsy analysis, six were examined during an early rejection crisis (day 7-70 post-graft), and five were examined during a late rejection crisis (day 74-960 post-graft). Since granzyme B and perforin are proteins associated with cell lysis histological grading and cell phenotype analysis, in situ hybridization using granzyme B and perforin [35S]RNA probes was performed on 30 EMB to characterize the cytolytic activation of heart infiltrating cells. Our data suggest that granzyme B and perforin could be used as predictive markers for acute rejection in patients with early rejection crisis. Their detection might be an indication to administrate corticoids to resolve an acute rejection crisis. In contrast, their absence in patients with late rejection crisis appears as a good prognostic factor for the outcome of rejection and raises the question of the necessity to treat such patients with additional corticoid treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1760412     DOI: 10.1093/intimm/3.11.1175

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  6 in total

1.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation.

Authors:  J Strehlau; M Pavlakis; M Lipman; M Shapiro; L Vasconcellos; W Harmon; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 2.  Perforin: An intriguing protein in allograft rejection immunology (Review).

Authors:  Ana-Maria Pașatu-Cornea; Elena Ciciu; Liliana-Ana Tuță
Journal:  Exp Ther Med       Date:  2022-06-15       Impact factor: 2.751

3.  Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.

Authors:  B Cowan; O Baron; J Crack; C Coulber; G J Wilson; M Rabinovitch
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

4.  Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2.

Authors:  M B Leger-Ravet; C Mathiot; A Portier; M Brandely; P Galanaud; W H Fridman; D Emilie
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

5.  Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms.

Authors:  Diana M Girnita; Steven A Webber; Maria M Brooks; Robert Ferrell; Alin L Girnita; Gilbert J Burckart; Richard Chinnock; Charles Canter; Linda Addonizio; Daniel Bernstein; James K Kirklin; David Naftel; Adriana Zeevi
Journal:  Transplantation       Date:  2009-06-27       Impact factor: 4.939

6.  Elevation of IGF-2 receptor and the possible underlying implications in end-stage heart failure patients before and after heart transplantation.

Authors:  Yingjie Wei; Jun Li; Jie Huang; Xiaoling Zhang; Hong Zhao; Chuanjue Cui; Yishi Li; Shengshou Hu
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.